The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed ...

Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

From healthcare to banking, it is the software-of-choice for some of the biggest names in the UK market. Think AstraZeneca (AZN.L), GSK (GSK.L), Rolls-Royce (RR.L) and Lloyds (LLOY.L). Even the London ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 billion in ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

Donald Trump returning to the White House triggered new index records in the US, and major UK companies are likely to feel ...

A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

Profit at the UK arm of software giant Workday almost doubled during its latest financial year, it has been revealed.